Illumina News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

30.04.20	Illumina Reports Financial Results for First Quarter of Fiscal Year 2020 (Businesswire)
29.04.20	Spende von Illumina erweitert die Ressourcen des Africa Centre for Disease Control and Prevention für die auf Sequenzierung basierende COVID-19-Kontrolle (Businesswire)
28.04.20	Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance (Businesswire)
16.04.20	Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19 (Businesswire)
14.04.20	Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020 (Businesswire)
27.02.20	Illumina Files Additional Patent Infringement Suit Against BGI in the U.S. (Businesswire)
12.02.20	Illumina to Webcast Upcoming Investor Conference Presentations (Businesswire)
06.02.20	Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors (Businesswire)
29.01.20	Illumina Issues FY20 Guidance - Quick Facts (RTTNews)
29.01.20	Illumina Inc. Q4 adjusted earnings Beat Estimates (RTTNews)
13.01.20	Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020 (Businesswire)
13.01.20	Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics (Businesswire)
13.01.20	Illumina and Roche Partner to Broaden Patient Access to Genomic Testing (Businesswire)
10.01.20	Illumina reicht Patentverletzungsklage gegen BGI in Schweden und dem Vereinigten Königreich ein (Businesswire)
10.01.20	Illumina Files Patent Infringement Suits Against BGI In Sweden And U.S. (RTTNews)
10.01.20	Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom (Businesswire)
02.01.20	Illumina and Pacific Biosciences Announce Termination of Merger Agreement (Businesswire)
23.12.19	Illumina to Webcast Upcoming Investor Conference Presentation (Businesswire)
20.11.19	Illumina to Webcast Upcoming Investor Conference Presentations (Businesswire)
24.10.19	Illumina Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
24.10.19	Illumina Reports Financial Results for Third Quarter of Fiscal Year 2019 (Businesswire)
08.10.19	Illumina to Announce Third Quarter 2019 Financial Results on Thursday, October 24, 2019 (Businesswire)
07.10.19	Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests (Businesswire)
30.09.19	Illumina and Broad Institute Announce Agreement to Co-Develop Genomic Secondary Analysis Tools (Businesswire)
23.09.19	Illumina Names Joydeep Goswami Senior Vice President of Corporate Development and Strategic Planning (Businesswire)
12.09.19	Illumina Recommends Stockholders Reject Mini-Tender Offer by TRC Capital Corporation (Businesswire)
29.07.19	Illumina Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
16.07.19	Illumina Expands Genomics Accelerator to Cambridge, UK (Businesswire)
11.07.19	Illumina Lowers Revenue Outlook, Shares Sink 16% (RTTNews)
11.07.19	Illumina Reports Preliminary Revenue for Second Quarter of Fiscal Year 2019 (Businesswire)
28.06.19	Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US (Businesswire)
17.06.19	Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc. (Businesswire)
04.06.19	Illumina Introduces Expanded Version of VeriSeq™ NIPT Solution, Offering More Comprehensive Detection of Rare Chromosomal Conditions (Businesswire)
29.05.19	Illumina to Webcast Upcoming Investor Conference Presentation (Businesswire)
15.05.19	Illumina Files Patent Infringement Suit Against BGI in Denmark (Businesswire)
01.05.19	Illumina to Webcast Upcoming Investor Conference Presentation (Businesswire)
25.04.19	Illumina Reports Financial Results for First Quarter of Fiscal Year 2019 (Businesswire)
09.04.19	Illumina to Announce First Quarter 2019 Financial Results on Thursday, April 25, 2019 (Businesswire)
29.03.19	Illumina Files Patent Infringement Suit Against BGI in Germany (Businesswire)
26.03.19	Illumina and the Lundbeck Foundation GeoGenetics Centre Collaborate to Generate One of the Largest Ancient Genome Datasets to Decode the Genetic Origins and Evolution of Mental Health Issues (Businesswire)
28.02.19	Illumina to Webcast Upcoming Investor Conference Presentation (Businesswire)
06.02.19	Illumina Names Susan E. Siegel to Its Board of Directors (Businesswire)
29.01.19	Illumina Inc. Q4 adjusted earnings Miss Estimates (RTTNews)
29.01.19	Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2018 (Businesswire)
15.01.19	Illumina to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Tuesday, January 29, 2019 (Businesswire)
20.12.18	Illumina to Webcast Upcoming Investor Conference Presentations (Businesswire)
06.12.18	Illumina Announces a New Genotyping Array and Scientific Contribution to Three Genome Centers to Support the All of Us Research Program (Businesswire)
13.11.18	Illumina to Webcast Upcoming Investor Conference Presentations (Businesswire)
01.11.18	Illumina To Acquire Pacific Biosciences At $8.00/shr - Quick Facts (RTTNews)
30.10.18	Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

20.11.24		Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone
20.11.24		Schwacher Handel: NASDAQ 100 schwächelt mittags
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer
19.11.24		Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind
18.11.24		Pluszeichen in New York: NASDAQ 100 zum Ende des Montagshandels in Grün
18.11.24		Börse New York in Grün: Börsianer lassen NASDAQ 100 nachmittags steigen
18.11.24		NASDAQ-Handel: NASDAQ 100 zeigt sich am Montagmittag fester

20.11.24

Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus

20.11.24

Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone

20.11.24

Schwacher Handel: NASDAQ 100 schwächelt mittags

20.11.24

Schwacher Wochentag in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer

19.11.24

Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind

18.11.24

Pluszeichen in New York: NASDAQ 100 zum Ende des Montagshandels in Grün